When credibility is critical, choose a partner that inspires confidence.

When complex financial problems arise, Gleason Experts helps clients minimize risk exposure, consider alternative scenarios, project results and take advantage of strategic opportunities.

Gleason IP takes a client-focused, cost-effective approach to IP issues, delivering insightful economic and financial analyses across a range of industries, with particular knowledge/expertise in Pharma/Life Sciences.

Gleason Trust has decades of experience in trust accounting, trust management and administration, and providing high-quality service to meet the fiduciary needs of a variety of trusts.

Gleason Advisors provides valuable financial and strategic advice to closely held, private companies throughout the business life cycle. Our experience spans multiple industries and challenges.

Certainty of Service in Uncertain Times

The health and well-being of our employees, clients, colleagues and community is our top priority. With the on-going COVID-19 outbreak, we have shifted the GLEASON team to a remote work status. Rest assured, we are still fully operational and remain committed to delivering the same level of quality service our clients have come to know and expect.

Value Beyond Dispute

Gleason is committed to providing honest, independent, objective opinions on financial and economic issues, supported by thoughtful, thorough analysis and relevant, reliable data. Our unmatched experience and integrity repeatedly produce results that withstand detailed – and often ruthless – examination.
Since 1988, our clients have found exceptional value in our insights. We are a trusted and proven partner in disputed, high risk scenarios that require specialized valuation and financial analysis.
Thousands of clients across the nation rely on our proficiency in accounting, tax, finance and economics. Our seasoned professionals hold credentials including CPA, CFA, CFE and MBA, and their expertise is widely recognized.

News and Press

Gleason IP Testimony Supports Client’s Successful Case

August 3, 2020

Gleason IP provided expert testimony on behalf of Teva Pharmaceuticals to establish that the asserted patent claims allegedly covering Adapt Pharma’s opioid overdose drug were invalid due to obviousness, and that the marketplace performance of Narcan® was attributable to features already known in the prior art, among other extrinsic factors unrelated to the Patents-in-Suit. Engagement In...   Read More

Remote Depositions in Response to COVID-19

August 3, 2020

The COVID-19 pandemic and related stay-at-home directives have led to an increase in remote depositions.  Historically, attorneys have been reluctant to conduct remote depositions, but there can be certain advantages to be gained from their adoption.  On several occasions, Gleason Managing Directors have been deposed virtually and are providing insight for consideration to aid in...   Read More

Find out about Careers at Gleason

We’re always on the lookout for talented new additions to the Gleason team.

Learn More